Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMPR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,975
Award facts
- Contract value 100% obligated
- $16,974.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,974.59 firm fixed-price delivery order (4570331587) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that positions the company as a critical regional pharmaceutical supplier for Department of Defense healthcare operations.
Under the PPV-G GEN V contract vehicle—designated SPE2DR with a $499.99 million ceiling value and completion date of December 31, 2036—DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products to military healthcare facilities worldwide. The company's product portfolio encompasses branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables, including oncology treatments, immunosuppressants, emergency medications, surgical products, and routine pharmaceuticals. The contract structure enables the Defense Logistics Agency to issue firm fixed-price delivery orders for recurring medical supply needs, with this particular order representing one of numerous awards demonstrating the contractor's established performance capability across diverse and specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMPR?
SPE2DU26FEMPR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DU26FEMPR worth?
The government has obligated $16,975 on SPE2DU26FEMPR.
Is contract SPE2DU26FEMPR an order under another contract?
Yes. SPE2DU26FEMPR is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMPR competed?
The extent of competition for SPE2DU26FEMPR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award